News & Stories

Important Update on Insurance Denials by Cigna and Others of Drugs Approved to Treat ALS

We continue to press Cigna to reverse course and make Relyvrio treatment available for people living with ALS on Cigna plans. While Cigna initially revised its policy, those changes were insufficient to ensure timely access to Relyvrio for people living with ALS.

Cigna is putting profits above the lives of people living with ALS. The additional burdens it is placing on families by limiting access to an FDA-approved medication are cruel and outrageous.

We know fighting a multi-billion-dollar insurance company is a David-and-Goliath fight, but our community is willing to do whatever it takes to ensure people living with ALS get the care they need and deserve.

We encourage people living with ALS who have been denied access to treatment by their insurance company to file official complaints with their state insurance commissioners. These complaints can spur regulators to issue formal findings against a company for inappropriately restricting access to treatments.

If your insurance company has denied you access to a drug approved to treat ALS, file a complaint with your state insurance commissioner, click here. This document will help guide you through the process.

Share This Article: